Clinical trials sponsored by SystImmune Inc.
3
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 3
Conditions studied
Recruiting trials led by SystImmune Inc.
- Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Common questions
How many trials is SystImmune Inc. recruiting for?
SystImmune Inc. is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.